Introduction
Calcific aortic stenosis (AS) is the most common cardiovascular (CV) disease after hypertension and coronary artery disease (CAD) in developed countries. 1, 2 The pattern of the left ventricular (LV) adaptive response to pressure overload in AS is heterogeneous and includes concentric remodelling (CR), concentric hypertrophy (CH), and eccentric hypertrophy (EH). 3, 4 The pattern and magnitude of LV hypertrophic remodelling is influenced not only by AS severity but also by several other factors including age, sex, genetic factors, metabolic factors and the coexistence of CAD, hypertension, aortic or mitral regurgitation. [5] [6] [7] [8] [9] [10] [11] Although the development of LV concentric remodelling or hypertrophy is a physiological response to an increased wall stress aiming to maintain LV ejection fraction (LVEF) and cardiac output, this adaptive response may eventually lead to the development of myocardial fibrosis and potentially irreversible myocardial dysfunction. [12] [13] [14] Previous studies suggest that severe LV hypertrophy (LVH) is associated with increased risk of cardiac events and mortality in AS patients both prior and after aortic valve replacement (AVR). 10, 11, [15] [16] [17] [18] [19] [20] However, there are very limited data on the impact of the different LV remodelling patterns on all-cause mortality in the AS population. The objective of this study was to examine the association between the LV remodelling patterns and mortality in patients with AS and preserved LVEF. 
Methods Patient population
We retrospectively analysed the clinical and Doppler echocardiographic data that were prospectively collected in consecutive patients with AS (inclusion criteria: peak aortic jet velocity > 2.0 m/s) who underwent a comprehensive transthoracic echocardiogram (TTE) at the Québec Heart & Lung Institute between 1999 and 2007. Patients were excluded if they presented the following criteria: (i) LVEF < 50%, (ii) > _moderate aortic regurgitation, (iii) > _moderate mitral stenosis or regurgitation, (iv) previous valve intervention, or (v) incomplete clinical and/or Doppler echocardiographic data. According to these criteria, a total of 747 patients were included in this analysis. The study was approved by the Ethics Committee of the Quebec Heart and Lung Institute, and written informed consent was waived for this retrospective analysis. 
Clinical data

Doppler echocardiographic data
All patients underwent a comprehensive TTE exam with Sonos 5500 or IE33 (Philips Healthcare), or using Vivid 7 or 9 (GE) and images were stored digitally. All TTE exams were performed and analysed in the same laboratory by the same team of sonographers and cardiologists following the recommendations of American Society of Echocardiography (ASE) and European Association of Echocardiography [EAE; nowadays European Association of Cardiovascular Imaging (EACVI)]. [21] [22] [23] The echocardiographic data were collected prospectively at the time of the echocardiography and entered in a computerized database.
Aortic valve morphology and function
Stroke volume was calculated by multiplying the LV outflow tract area by the flow velocity-time integral and was indexed to BSA (SVi) or to a 2.04 power of height (SVi 2.04 ). 9, [24] [25] [26] [27] The echocardiographic indices of AS severity included peak aortic jet velocity, mean transvalvular pressure gradient, and aortic valve area calculated by the standard continuity equation and indexed to BSA (AVAi) or to a 2.04 power of height (AVAi 2.04 ). The degree of aortic and mitral regurgitation was classified according to the recommendations of the ASE-EAE/EACVI. 28, 29 LV geometry and function LV minor axis internal dimension (LVID), posterior wall thickness (PWT), and inter-ventricular septal thickness (IVST) were measured according to the recommendations of the ASE-EAE/EACVI. 21, 23 LVEF was measured with the use of the biplane Simpson method. The relative wall thickness (RWT) was calculated [i.e. RWT = (PWT þ IVST)/LVID] and, as recommended, RWT >0.42 was used to define CR (Figure 1) . 23 LV mass was calculated with the corrected formula of the ASE-EAE/EACVI 23 as follows:
]þ0.6 LVM was further indexed to BSA (LVMi) or to a 2.7 power of height (LVMi 2.7 ), as previously described to adjust for the effect of obesity on BSA.
9,25-27,30-32 LVH was defined as LVMi 2.7 >49 g/m 2.7 in men and >47 g/m 2.7 in women ( Figure 1) . 9, 25, 26, [30] [31] [32] By taking into account both values of LVMi 2.7 and RWT, patients were classified into four different patterns using the following criteria proposed in the ASE-EACVI guidelines ( Figure 1 
Global LV haemodynamic load
As a measure of global LV haemodynamic load, we calculated the valvuloarterial impedance: Z va = (SBP þ DP mean )/SVi where SBP is the systolic blood pressure, DP mean the mean transvalvular gradient, and SVi is the stroke volume indexed to BSA (Z va ) or to a 2.04 power of height (Z va 2.04 ). 9, 26, 27, 33 Study end-points
The study end-points were all-cause mortality and CV mortality. The last update of the clinical events was obtained in all patients from Quebec National Institute of Statistics in January 2013.
Statistical analysis
Continuous data were expressed as mean ± standard deviation or median [interquartile range]. The continuous variables were tested for normality of distribution and homogeneity of variances with the ShapiroWilk and Levene tests, respectively. LV remodelling patterns were compared with one-way ANOVA followed by a Tukey's post hoc test when This figure shows the definition and prevalence of LV remodelling patterns in the studied AS population.
LV remodeling and outcomes in AS patients appropriate. Categorical data were expressed as percentage and compared with the v 2 test or Fisher's exact test when appropriate.
Kaplan-Meier curves and log-rank tests of the time-to-event data were used to assess the effect of LV remodelling patterns on all-cause and CV mortality. The relationships between RWT, LVMi 2.7 or CH pattern and outcomes were assessed with the use of univariable and multivariable Cox proportional hazard analyses. The proportional-hazards assumption was checked with the use of Schoenfeld residuals. The clinically relevant variables and those with P-value <0.10 were entered in the multivariable Cox models (i.e. age, sex, BMI, hypertension, diabetes, CAD, COPD, renal failure, AVAi 2.04 , SVi 2.04 , and LVEF). The impact of AVR, defined as a time-dependent variable, on all-cause and CV mortality was analysed in multivariable Cox models. A P-value <0.05 was considered statistically significant.
Results
Patient characteristics
The characteristics of the 747 patients included in this study are presented in Table 1 . The mean age was 69 ± 14 years and 57% were men. Seventy percent of patients had hypertension, 25% were obese (i.e. BMI > _ 30 kg/m 2 ), 25% had diabetes, and 52% had history of CAD. Among the 658 patients (88% of the whole cohort) with evaluation of symptomatic status, 73% presented symptoms (NYHA class > _2 and/or angina). Concerning the echocardiographic data, 29% of patients had a bicuspid aortic valve and 52% had severe AS.
One hundred sixteen patients (15%) had normal pattern, 66 (9%) had EH, 169 (23%) had CR, and 396 (53%) had CH in this cohort of AS patients with preserved LVEF (Figure 1) . None of the patients included in this study had obstructive LVH (i.e. defined as LV outflow tract peak gradient >30 mm Hg). The baseline characteristics of patients according to LV remodelling patterns were presented in Table  1 . Concentric patterns (i.e. CR and CH), and especially CH, were more prevalent in older (P = 0.009), obese (P < 0.0001), and hypertensive (P = 0.01) patients ( Figure 2C , D, and F). There was only a trend for higher prevalence of CH in men compared with women (P = 0.08), as well as in those with diabetes (P = 0.07) ( Figure 2B and E). Patients with more severe AS (P < 0.0001; Figure 2G ; see Supplementary data online, figure S1, Panels A-C) and higher global LV afterload (P < _ 0.001; see Supplementary data online, Figure S1D and E) had higher prevalence of CH.
LV remodelling and outcomes: impact on all-cause and CV mortality
During the median follow-up of 6.4 years [IQR: 2.6-8.7 ], there were 339 deaths, of which 242 were from CV cause, and 442 patients underwent AVR (including transcatheter AVR in 23 patients) and 112 underwent concomitant coronary artery bypass grafting at the time of AVR. Despite similar length of follow-up in women vs. men (6.4 [2. 6-8.7 ] vs. 6.4 [2.7-8.6 ] years, P = 0.96), AVR was less often performed during follow-up in women [164 (51%) AVRs (29 with concomitant CABG)] vs. in men [278 (66%) AVRs (83 with concomitant CABG)] (P < 0.001). There was a significant association (P = 0.0005; Figure 3A ) between LV remodelling patterns and all-cause mortality: patients with CH pattern presented the worst survival compared with the three other LV patterns (6 year survival rate: CH = 61% vs. normal = 70% or EH = 71% or CR = 70%; all P < 0.05; Figure 3A) .
In univariable Cox analysis, RWT, LVMi 2.7 , and CH pattern were significantly associated with all-cause mortality (RWT per 0. Table 2 ) was independently associated with allcause mortality, whereas there was only a trend for RWT and LVMi 2.7 (RWT: HR = 1.08, 95% CI 0.99- 1.19 , P = 0.091; LVMi 2.7 : HR = 1.08, 95% CI 0.99- 1.16 , P = 0.066; Model #1, Table 2 ). Similarly, there was a significant association (P = 0.0006) between LV remodelling patterns and CV mortality: CH was associated with worse outcome compared with the three other groups (all P < 0.05; see Supplementary data on line, Figure S2A There was no significant interaction between the time period of the baseline echocardiography and the LV remodelling patterns with respect to impact on outcomes (all P > 0.70), suggesting that timing of the baseline exam did not have significant effect on the results.
Sex-difference according to the impact of LV remodelling on outcomes
There was a significant interaction between sex and CH pattern with regards to the prediction of all-cause mortality (P = 0.02) and CV mortality (P = 0.03). The baseline characteristics of patients according to sex were presented in Supplementary data online, Table S2 . There was a significant association between LV remodelling patterns and allcause mortality in women (158 deaths; P = 0.0001; Figure 3B ), but not in men (181 deaths; P = 0.22; Figure 3C ). Women who had CH presented the worst outcomes compared with those without CH, as well as men with and without CH (all P < 0.05; Figure 4 ). In the subset of women, CH pattern was associated with higher rate of all-cause mortality compared with the other LV patterns (all P < 0.05; Figure  3B ). Consistently, in univariable Cox analysis, RWT, LVMi 2.7 , and CH pattern were significantly associated with all-cause mortality in women (all P < 0.001; Table 2 ). In this subset of patients, after multivariable adjustment, LVMi 2.7 (HR = 1.16, 95% CI 1.02-1.31, P = 0.019) and CH pattern (HR = 1.56, 95% CI 1.08-2.24, P = 0.018) were independently associated with all-cause mortality, and there was a trend for RWT (HR = 1.12, 95% CI 1.00-1.27, P = 0.054) (Model #2, Table 2 ). In men, even if RWT was significantly associated with all-cause mortality in univariable analysis (P = 0.006), after similar 2.7 , nor CH pattern was associated with all-cause mortality (all P > _ 0.60; Model #3, Table 2 ).
The analysis of CV mortality provided comparable results (see Supplementary data online, Figure S2B and C and Values are mean ±SD.
The following symbols indicate the significance of the Tukey's post hoc test: *P < 0.05 from 'Normal pattern', ¶ P < 0.05 from 'EH', § P < 0.05 from 'CR'. † P-value of the one-way ANOVA.
BSA, body surface area; BMI, body mass index; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; IVST, inter-ventricular septal thickness; PWT, posterior wall thickness; LVID, left ventricular internal diameter; RWT, relative wall thickness; LVEF, left ventricular ejection fraction. 2.04 , stroke volume indexed to height 2.04 , and LVEF. 2.7 was strongly correlated to LV mass indexed to BSA (LVMi: r = 0.92; P < 0.0001). Using LVH defined by LVMi (i.e. LVMi >115 g/m 2 in men and >95 g/m 2 in women), the results regarding the relationship between LVMi or CH and all-cause or CV mortality were similar to those obtained with LVMi 2.7 , even if there was a slight difference in the distribution of LV remodelling patterns according to LVH defined by LVMi vs. LVMi 2.7 ( Figure 1A ).
Discussion
The main findings of this study are as follows: (i) in the present cohort of AS patients with preserved LVEF, CH is the most prevalent pattern followed by CR, whereas EH is rare; (ii) older age, obesity, hypertension, more severe AS, and higher Z va are associated with higher prevalence of CH; (iii) CH is independently associated with increased mortality, even after adjustment for the factors mentioned above and for AVR; and (iv) this association was observed in women but not in men.
LV remodelling in AS
The LV pressure overload related to AS and/or systemic hypertension generally leads to an LV concentric physiologic response with increased wall thickness relative to LV cavity, which limits wall stress to allow for maintenance of normal LV systolic function. 3, 12, 13 Although CR is often considered as the earliest phase on the LV concentric adaptive response to LV pressure overload, a substantial proportion of patients with severe AS remain in CR and never develop CH. In this study that included the whole spectrum of AS, more than half (53%) of patients had CH and 23% had CR and among those with severe AS, 60% had CH and 22% CR. In this cohort with preserved LVEF, the prevalence of EH was, as expected, relatively low (9%). The fact that an important proportion of patients with mild-tomoderate AS nonetheless have CH in this study may be explained, at least in part, by the presence of concomitant systemic hypertension that also contributes to increase the LV afterload. However, it is also interesting to note that in the lower tertile of Z va , which includes mostly patients with mild AS and no hypertension (i.e. patients with mildly increased global haemodynamic load), about 45% of them nonetheless had CH. This finding suggests that beyond the LV haemodynamic load imposed by AS and/or hypertension, other factors, including, age, obesity, metabolic syndrome, insulin resistance, and diabetes, may have an important contribution to the development of LV CR/CH in AS patients. [6] [7] [8] [9] 26, 27 These findings suggest that the metabolic milieu, per se, may induce LV CR and/or modulate the LV concentric adaptive response to pressure overload. Moreover, other factors not measured in this study, including genetic factors, may also influence the type and magnitude of the LV remodelling adaptive response to pressure overload. 6 The impact of LV remodelling patterns on outcomes in AS
In patients with AS, the presence of LVH is known to be associated with worse LV function, faster progression to symptoms, increased risk of cardiac events, as well as a higher operative risk for surgical AVR and worse mid-or long-term outcomes following surgical or transcatheter AVR. 6, 10, 11, [15] [16] [17] [18] [19] [20] However, until now, no study has evaluated the prognostic value of the different LV remodelling patterns in a large AS population with preserved LVEF. This is the first study to demonstrate that CH is a powerful independent predictor of mortality even after adjustment for the correlates of LV remodelling patterns and for the performance of AVR during follow-up. These findings suggest that CH may be associated with an outcome penalty despite successful AVR. These findings support the usefulness of LV remodelling assessment to improve risk stratification in AS patients with preserved LVEF. Several underlying factors and mechanisms may explain the association between CH and increased risk of mortality in AS. CH is associated with reorganization and loss of myocardial cells and development of fibrosis, which is a strong predictor of worse outcomes in AS patients. 12, 14, [34] [35] [36] [37] CH and to a lesser extent CR may also result in reduction of stroke volume and thus higher prevalence of paradoxical low flow (reduced stroke volume index despite preserved LVEF), which has been shown to be associated with worse outcomes in the AS population both before and after AVR. [38] [39] [40] [41] [42] [43] [44] Finally, other pathological mechanisms linked to adverse LV remodelling could explain worse outcomes in AS patients with CH: sub-endocardial ischaemia due to the mismatch between oxygen supply and oxygen need of the hypertrophied myocardium, reduced diastolic perfusion time, microvascular dysfunction, low coronary perfusion pressure, and/or genetic factors associated with LVH.
6,45-47
Sex-related differences in the impact of LV remodelling on outcomes
A previous study suggests that among individuals with mild or moderate AS, women tend to develop CR or CH more often, whereas men are more prone than women to develop EH. 5 Moreover, in patients with severe AS, other studies reported that women present more concentric LV remodelling pattern than men (i.e. higher RWT, lower LV sizes but similar LVM). [48] [49] [50] [51] [52] In this study that included the whole range of AS severity, there was a trend for more CH and less CR in men compared with women. One of the most striking results of this study was that the impact of CH on prognosis was much more pronounced in women than in men. Indeed, we demonstrated for the first time that CH was independently associated with a 60% increased risk of all-cause or CV mortality in women, whereas there was no significant association between CH and mortality in men. Consistent with these results, a recent study, limited to the analysis of post-AVR outcomes, reported that residual LVH after AVR is associated with increased mortality but this association is much stronger in women. 53 Other studies found that women are more likely than men to develop LV restrictive physiology pattern and heart failure in pressure overload cardiopathies. 6, 54 In response to pressure overload, women may develop a more pronounced form of CR and CH with more important reduction in LV cavity size, decrease in LV compliance and impairment of LV filling and pump function, compared with men. [48] [49] [50] [51] [52] The nature of the LV remodelling/hypertrophy may also be different in women vs. men with potentially more diffuse myocardial fibrosis in women. Some studies reported that, in the AS population, men tend to have more myocardial fibrosis than women but these studies were confounded by the higher prevalence of CAD in men and by the fact that they measured only focal fibrosis. 55, 56 Oestrogen, as opposed to testosterone, seems to protect against cardiac fibroblast proliferation. [57] [58] [59] However, the AS population is predominantly composed of patients >50 years old, and so the vast majority of women with AS are menopaused and have therefore lost, at least in part, the potential protective effect of oestrogen. Other factors could explain the sex-related difference in the impact of CH on outcomes in AS including the fact that, for various reasons, women are often referred to AVR at a later stage of disease compared with men. 60 Further studies are needed to elucidate the factors responsible for the differential impact of CH on outcomes in women vs. men with AS.
Clinical implications
In the guidelines for the management of valvular heart disease, the LV remodelling/hypertrophy pattern is not mentioned among the parameters that could be considered to support an indication for AVR. 61, 62 The ESC-EACTS guidelines however mention 'excessive' LVH as one of the criteria that could be considered to suggest (as a Class IIb recommendation) an AVR in asymptomatic patients with severe AS. 61 The results of this study as well as some recent studies would support the inclusion of CH as a criterion to recommend AVR in women with severe asymptomatic AS. Indeed further adjustment for AVR (defined as a time-dependent variable) did not affect the association between CH and mortality, which provides further support to the concept that CH has an independent long-term impact on prognosis in AS. These findings thus challenge the 'wait for symptoms or LV systolic dysfunction' strategy and would rather support an earlier AVR in patients with severe AS having CH, and particularly in women. However, further prospective studies are needed to (i) confirm our new findings, and, in particular, the potential outcome penalty despite successful AVR in AS patients with CH; and (ii) determine whether earlier intervention could provide a survival benefit in this population.
Study limitations
The main limitations of this work are that the study was conducted in a single centre and that data were prospectively collected but retrospectively queried. Hence, this study has the inherent limitation of a retrospective analysis. A prospective and multi-centre study is needed to confirm and further expand these findings, and especially those related to the differential impact of CH in men vs. women. However, to limit the potential bias associated with this analysis, we included a large series of consecutive patients whose exams were performed and analysed by same and experienced sonographers and cardiologists. Moreover, the mortality data were obtained from the Québec National Institute of Statistics improving the follow-up accuracy. The decision to perform an AVR was taken by the referent physician and could be influenced by his perception and interpretation of disease severity or patient's symptomatic status. Cardiac magnetic resonance imaging, which is a gold standard method to assess LV remodelling, was not available for this study. However, 2D TTE has a good reproducibility to evaluate LV geometry and it is the method that is currently recommended and largely used in practice to follow AS patients and trigger intervention. The baseline medication, the assessment of the severity of CAD, and the measurements of myocardial strain and fibrosis, as well as biomarkers, were not available in this study.
Conclusion
LV CH is independently associated with increased all-cause and CV mortality in women with AS and preserved LVEF but not in men. The assessment of LV remodelling patterns should be integrated to the risk stratification of AS patients, and women with LV CH should be followed closely. Further studies are needed to determine whether earlier AVR would improve outcomes in these patients.
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Supplementary data are available at European Heart Journal-Cardiovascular Imaging online.
